Pancreatic Cancer Research

ResearcherUniversity of Nebraska–LincolnNo recent work listed

Jaime Abrego

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8569-2741; OpenAlex author ID A5086355202. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
32
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 5 papers · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper

Papers 10

  1. CD73 induces GM-CSF/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis. Co-author DOI 10.1038/s41388-021-02132-6↗
  2. JNK signaling contributes to skeletal muscle wasting and protein turnover in pancreatic cancer cachexia. Co-author DOI 10.1016/j.canlet.2020.07.025↗
  3. Metabolic Alterations in Pancreatic Cancer Progression. First author DOI 10.3390/cancers12010002↗
  4. Evaluating the Metabolic Impact of Hypoxia on Pancreatic Cancer Cells. Co-author DOI 10.1007/978-1-4939-7665-2_8↗
  5. GOT1-mediated anaplerotic glutamine metabolism regulates chronic acidosis stress in pancreatic cancer cells. Co-author DOI 10.1016/j.canlet.2017.04.029↗
  6. MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer. Co-author DOI 10.1016/j.ccell.2017.06.004↗
  7. Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells. Co-author DOI 10.1021/acs.jproteome.7b00246↗
  8. De Novo Lipid Synthesis Facilitates Gemcitabine Resistance through Endoplasmic Reticulum Stress in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-16-3062↗
  9. MUC1-Mediated Metabolic Alterations Regulate Response to Radiotherapy in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-17-1151↗
  10. MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism. Co-author DOI 10.18632/oncotarget.4078↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Pankaj Kumar Singh · 10 shared papers, 2015–2022 · strength 0.77
  2. Surendra Kumar Shukla · 9 shared papers, 2015–2022 · strength 0.67
  3. Venugopal Gunda · 8 shared papers, 2015–2022 · strength 0.55
  4. Enza Vernucci · 7 shared papers, 2017–2022 · strength 0.54
  5. Aneesha Dasgupta · 6 shared papers, 2017–2022 · strength 0.49
  6. Nina V. Chaika · 7 shared papers, 2015–2022 · strength 0.48
  7. Ryan J. King · 6 shared papers, 2017–2022 · strength 0.47
  8. Divya Murthy · 5 shared papers, 2017–2022 · strength 0.46
  9. Scott E. Mulder · 3 shared papers, 2017–2022 · strength 0.31
  10. Kuldeep Singh Attri · 3 shared papers, 2017–2022 · strength 0.28
  11. Michael Anthony Hollingsworth · 2 shared papers, 2017–2022 · strength 0.16
  12. Paul M. Grandgenett · 2 shared papers, 2017–2022 · strength 0.16
  13. Saber Tadros · 2 shared papers, 2017 · strength 0.13
  14. Chunbo He · 1 shared paper, 2022 · strength 0.12
  15. Ravi Kumar Thakur · 1 shared paper, 2022 · strength 0.12
  16. Vinee Purohit · 2 shared papers, 2017 · strength 0.11
  17. Robert Powers · 2 shared papers, 2017 · strength 0.11
  18. Teklab Gebregiworgis · 2 shared papers, 2017 · strength 0.11
  19. Jean L. Grem · 2 shared papers, 2017 · strength 0.10
  20. Lyudmyla Derby Berim · 2 shared papers, 2017 · strength 0.10
  21. Joshua J. Souchek · 2 shared papers, 2015–2017 · strength 0.10
  22. Vikrant Rai · 1 shared paper, 2019 · strength 0.08
  23. Shuo Wang · 1 shared paper, 2017 · strength 0.06
  24. Chi H. Lin · 1 shared paper, 2017 · strength 0.06
  25. Dhanya Haridas · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.